Norway has demonstrated exceptional progress in its national response to HIV, effectively meeting international benchmarks. According to a recent study using linked registry data, the HIV continuum of care in the country shows remarkably high rates of linkage and treatment. These findings are crucial for medical professionals worldwide, especially as the global community strives to eliminate HIV as a public health threat by 2030.

Metrics of the HIV Continuum of Care in Norway

Researchers analyzed data from 5,847 people living with HIV (PLHIV) diagnosed through 2023. The results indicate that clinicians linked 99.6% of these individuals to specialist care. Furthermore, 96.4% of the cohort received antiretroviral therapy (ART). Among the 4,926 PLHIV still residing in Norway in 2023, 96.7% maintained retention in care. Additionally, 95.3% of the group had received ART within the prior 24 months, highlighting a consistent and robust follow-up system.

Impact on Mortality and Clinical Outcomes

The study also examined mortality rates to assess the long-term efficacy of these interventions. Specifically, the all-cause mortality rate stood at 4.7 per 1,000 person-years. In contrast, HIV/AIDS-specific mortality was 1.0 per 1,000 person-years among those without a concurrent AIDS diagnosis who used ART. Consequently, these figures suggest that early diagnosis and adherence to ART remain the cornerstones of survival. Moreover, the use of linked administrative and health registries provides a viable alternative for monitoring outcomes when a dedicated national clinical registry is absent.

Conclusion

Overall, Norway has achieved high levels of engagement in specialist HIV care. These results provide clear evidence of progress toward global clinical targets. Thus, the Norwegian model serves as a benchmark for utilizing comprehensive data systems to improve patient outcomes and guide public health strategies.

Frequently Asked Questions

What is the HIV continuum of care?

The HIV continuum of care is a public health model that tracks the stages of HIV care, including diagnosis, linkage to care, starting ART, and achieving viral suppression.

How did Norway monitor these outcomes?

Norway used linked data from various national health and administrative registries, covering the period from 2008 to 2023, to track outcomes like ART dispensation and retention.

What were the mortality findings for those on ART?

PLHIV on ART without a concurrent AIDS diagnosis at the time of study had the lowest HIV-specific mortality rate, recorded at 1.0 per 1,000 person-years.

Disclaimer: This content is for informational and educational purposes only and does not constitute medical advice or a professional opinion. Readers should consult with a qualified healthcare professional for specific medical concerns. Refer to the latest local and national guidelines for clinical practice.

References

1. Rakover A et al. The continuum of care and cause-specific mortality rate among persons diagnosed with HIV in Norway until the end of 2023. Infect Dis (Lond). 2026 Mar 23. doi: 10.1080/23744235.2026.2645363. PMID: 41871379.


2. UNAIDS. Global HIV & AIDS statistics — Fact sheet 2023. Available from: https://www.unaids.org/en/resources/fact-sheet.


3. World Health Organization (WHO). HIV statistics, globally and by WHO region, 2024. Available from: https://www.who.int/news-room/fact-sheets/detail/hiv-aids.